TLR5
Basic information
Region (hg38): 1:223109404-223143292
Previous symbols: [ "SLEB1" ]
Links
Phenotypes
GenCC
Source: 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_specified (95 variants)
- not_provided (15 variants)
- TLR5-related_disorder (3 variants)
- Systemic_lupus_erythematosus,_susceptibility_to,_1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TLR5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003268.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 7 | |||||
| missense | 82 | 15 | 100 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 1 | 82 | 19 | 6 | 
Highest pathogenic variant AF is 6.840488e-7
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| TLR5 | protein_coding | protein_coding | ENST00000540964 | 1 | 33877 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 2.48e-13 | 0.0359 | 112631 | 459 | 12658 | 125748 | 0.0536 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.392 | 407 | 430 | 0.947 | 0.0000215 | 5688 | 
| Missense in Polyphen | 102 | 117.92 | 0.86498 | 1695 | ||
| Synonymous | -0.326 | 178 | 173 | 1.03 | 0.00000884 | 1683 | 
| Loss of Function | 0.206 | 20 | 21.0 | 0.951 | 0.00000109 | 289 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.0481 | 0.0480 | 
| Ashkenazi Jewish | 0.0286 | 0.0286 | 
| East Asian | 0.0282 | 0.0282 | 
| Finnish | 0.0465 | 0.0467 | 
| European (Non-Finnish) | 0.0625 | 0.0623 | 
| Middle Eastern | 0.0282 | 0.0282 | 
| South Asian | 0.104 | 0.103 | 
| Other | 0.0504 | 0.0506 | 
dbNSFP
Source: 
- Function
- FUNCTION: Participates in the innate immune response to microbial agents. Mediates detection of bacterial flagellins. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. {ECO:0000269|PubMed:11323673}.;
- Disease
- DISEASE: Systemic lupus erythematosus 1 (SLEB1) [MIM:601744]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Salmonella infection - Homo sapiens (human);Legionellosis - Homo sapiens (human);Inflammatory bowel disease (IBD) - Homo sapiens (human);Toll-like receptor signaling pathway - Homo sapiens (human);Pathogenic Escherichia coli infection - Homo sapiens (human);Regulation of toll-like receptor signaling pathway;Pathogenic Escherichia coli infection;Toll-like Receptor Signaling;Simplified Depiction of MYD88 Distinct Input-Output Pathway;Toll-like Receptor Signaling Pathway;MyD88 cascade initiated on plasma membrane;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll-Like Receptors Cascades;Innate Immune System;Immune System (Consensus) 
Recessive Scores
- pRec
- 0.266
Intolerance Scores
- loftool
- 0.654
- rvis_EVS
- 1.65
- rvis_percentile_EVS
- 96.21
Haploinsufficiency Scores
- pHI
- 0.0769
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.400
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.974
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
- Tlr5
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype;
Gene ontology
- Biological process
- MyD88-dependent toll-like receptor signaling pathway;inflammatory response;positive regulation of interleukin-8 production;positive regulation of toll-like receptor signaling pathway;toll-like receptor 5 signaling pathway;defense response to bacterium;innate immune response;regulation of cytokine secretion;cellular response to mechanical stimulus
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- transmembrane signaling receptor activity;interleukin-1 receptor binding